Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1031 | 1031 | 1068 | 998 | 1327 | 1264 |
Fund Return | 3.13% | 3.14% | 6.75% | -0.05% | 5.82% | 2.37% |
Place in category | 1148 | 1165 | 1114 | 1410 | 820 | 637 |
% in Category | 54 | 56 | 56 | 78 | 53 | 69 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Global Asia REIT AA G | 280.01M | -4.99 | -4.98 | - | ||
Manulife Global Fund Global Equity | 256.46M | 6.62 | 5.49 | 6.43 | ||
Manulife Glbl Fund Asian Eq Fund I | 110.62M | 6.29 | -6.89 | 3.66 | ||
Manulife Glbl Fund Asian Eq Fund AA | 110.62M | 6.01 | -7.62 | 2.92 | ||
Manulife Glbl Fund Asian Eq I3 USD | 110.62M | -17.66 | 4.06 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFSM European Value Fund A1 USD | 2.74B | -1.29 | 1.47 | 4.99 | ||
MFSM European Value Fund I1 USD | 2.74B | -1.14 | 2.48 | 6.03 | ||
MFSM European Value Fund N1 USD | 2.74B | -1.35 | 0.97 | 4.46 | ||
MFSM European Value Fund W1 USD | 2.74B | -1.16 | 2.23 | 5.78 | ||
Europe Equity Plus Fund A perf acc | 1.9B | 9.06 | 6.71 | 4.68 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 5.52 | 853.00 | -1.33% | |
Novo Nordisk B | DK0062498333 | 5.38 | 909.9 | +3.02% | |
SAP | DE0007164600 | 3.42 | 176.680 | +0.35% | |
AstraZeneca | GB0009895292 | 3.20 | 12,318.0 | -0.42% | |
Louis Vuitton | FR0000121014 | 3.11 | 782.60 | -0.74% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review